Finding pathways across biological barriers for delivering life-saving drugs is entering a new era with the rapid advancement of computational resources. My research group focuses on developing simulation methods to elucidate the interfacial phenomenon associated with biological barriers that play a role in life-threatening diseases such as Alzheimer’s, cancer, and chronic infections. Our goal is to influence this experimentally dominated research field by providing mechanistic, structural, and molecular insights into the barrier functions that were computationally unattainable before our work. In the past few years, we have made breakthroughs in understanding the molecular architecture of the blood-brain barrier and developed strategies to enhance the barrier’s permeability for the treatment of neurodegenerative disease. In my talk, I will elaborate on the computational methods we have developed to investigate the blood-brain barrier and provide a perspective on the treatment of Alzheimer’s disease.

Treating Alzheimer’s disease: A molecular challenge

ACS Spring 2022

The official archive and repository for all ACS Meetings & Expositions abstracts and select posters or presentations.